2nd Annual MarketsandMarkets

Next-Gen Immuno-Oncology Conference - West Coast Edition

6th - 7th February 2025

San Diego, USA

Unleashing the Power of Immunity: Strategies for Fighting Cancer

Embark on a journey into the future of cancer treatment at our immersive MarketsandMarkets 2nd Annual Next-Gen Immuno-Oncology Conference, coming up on 6th – 7th February in San Diego - Finest city of America. The Congress sets on a theme where innovation knows no bounds and breakthroughs are the norm. Step into a realm where the immune system becomes the ultimate superhero in the battle against cancer.

Exploring pioneering immunotherapies, impact of bispecific antibodies and antibody-drug conjugates (ADCs), strategies for personalized vaccines, groundbreaking cellular therapies. Additionally, the conference will shed light on current regulatory challenges, recent market trends, techniques for monitoring treatment effectiveness, and the increasing role of AI and machine learning in cancer immunology.

Seize the opportunity to engage with leading minds from around the world, exchange ideas, and ignite collaborations that will shape the future of cancer care. From captivating keynotes, clinical case studies to interactive workshops, explore the cutting edge of science and technology driving progress in the fight against cancer.

Join us on this journey as we look forward towards a brighter tomorrow, where cancer is no longer a formidable foe but a conquerable challenge.


10th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference - West Coast Edition


  • Emerging Technologies in IO Targeting & Discovery: Advancements in preclinical models, translational research & targeted therapies.
  • Regulatory Challenges and Market Trends: Addressing Regulatory hurdles and navigating market trends associated with the development & commercialization of new immuno-oncology therapies.
  • Cell-Based Immunotherapies: Enhancements of CAR-T Cell, NK Cell Therapies, TIL, TCR & Adoptive cell transfer.
  • Tumor Microenvironment Modulation: Strategies to modify the tumor microenvironment enhancing immune cell infiltration and activity. 
  • Bispecific Antibodies and Antibody-Drug Conjugates: Merging the benefits of both BsAbs and ADCs, improving specificity and therapeutic efficacy.
  • Next-Gen Immune Checkpoints & Combination Therapies:  Discovery and targeting of novel immune checkpoints and combining them with other treatment modalities to enhance overall efficacy and overcome resistance.
  • Personalized Cancer Vaccines: Creation of personalized vaccines targeting specific neoantigens.
  • Real-time Monitoring and Biomarkers: Development of advanced techniques for real-time monitoring of treatment responses and identification of novel biomarkers to assess immunotherapy effectiveness.
  • Predictive Analytics: AI and ML applications in analysing genetic alterations to predict and evaluate actionable targets for cancer treatment.
  • Synthetic Biology in Immunotherapy: Applications of synthetic biology to engineer immune cells with new functionalities, such as synthetic receptors and logic circuits.
  • mRNA-based Immunotherapies: Utilizing mRNA technology to develop cancer immunotherapies.
  • Case Studies: Highlighting successful and real-world applications of immuno-oncology treatments.

  • Explore Breakthroughs in Antibodies, Cellular Therapy, and Immune-Checkpoint Research in One Place.
  • Stay Updated with the Latest Immuno-Oncology Case Studies.
  • Experience Cutting-Edge Platforms and Technologies in Immuno-Oncology Development.
  • Exchange Insights on Optimal Research Tools for Immuno-Oncology Studies.
  • Present Your Work and Achievements to Industry Peers in Exhibitions & Poster Sessions.

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows working on

  • Regulatory Affairs
  • Research and Development (R&D)
  • Biomedical Engineering
  • Oncology and Pharmacology
  • Preclinical/Translational Science
  • Immunology/Immuno-oncology
  • Monoclonal and Bispecific Antibodies
  • Cell Therapy & Biomarker discovery
  • Immune Checkpoint Inhibitors




San Diego, USA